Postoperative Radiotherapy for Resected Stage IIIA-N2 Non-small-cell Lung Cancer: A Population-Based Time-Trend Study
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Postoperative Radiotherapy for Resected Stage IIIA-N2 Non-small-cell Lung Cancer: A Population-Based Time-Trend Study
Authors
Keywords
-
Journal
LUNG
Volume 197, Issue 6, Pages 741-751
Publisher
Springer Science and Business Media LLC
Online
2019-11-09
DOI
10.1007/s00408-019-00284-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non–Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database
- (2017) Alex Herskovic et al. Journal of Thoracic Oncology
- Lung cancer: current therapies and new targeted treatments
- (2017) Fred R Hirsch et al. LANCET
- Postoperative radiotherapy for lung cancer: Is it worth the controversy?
- (2016) Charlotte Billiet et al. CANCER TREATMENT REVIEWS
- The Differential Impact of Postoperative Radiation Therapy for Completely Resected Stage IIIA (N2) Non-Small Cell Lung Cancer: Based on the Risk Prediction Model for Locoregional Recurrence
- (2016) W. Feng et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Intensity-Modulated Radiation Therapy May Improve Local-Regional Tumor Control for Locally Advanced Non-Small Cell Lung Cancer Compared With Three-Dimensional Conformal Radiation Therapy
- (2016) J. Wang et al. ONCOLOGIST
- 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer
- (2015) W. E. E. Eberhardt et al. ANNALS OF ONCOLOGY
- The emerging outcome of postoperative radiotherapy for stage IIIA(N2) non-small cell lung cancer patients: based on the three-dimensional conformal radiotherapy technique and institutional standard clinical target volume
- (2015) Wen Feng et al. BMC CANCER
- Postoperative Radiotherapy for Pathologic N2 Non–Small-Cell Lung Cancer Treated With Adjuvant Chemotherapy: A Review of the National Cancer Data Base
- (2015) Cliff G. Robinson et al. JOURNAL OF CLINICAL ONCOLOGY
- VATS Versus Open Surgery for Lung Cancer Resection: Moving Toward a Minimally Invasive Approach
- (2015) Jacob Klapper et al. Journal of the National Comprehensive Cancer Network
- The 2015 World Health Organization Classification of Lung Tumors
- (2015) William D. Travis et al. Journal of Thoracic Oncology
- Postoperative Radiotherapy is Associated with Better Survival in Non–Small Cell Lung Cancer with Involved N2 Lymph Nodes: Results of an Analysis of the National Cancer Data Base
- (2015) John L. Mikell et al. Journal of Thoracic Oncology
- Re-evaluation of the Role of Postoperative Radiotherapy and the Impact of Radiation Dose for Non–Small-Cell Lung Cancer Using the National Cancer Database
- (2015) Christopher D. Corso et al. Journal of Thoracic Oncology
- PET in the management of locally advanced and metastatic NSCLC
- (2015) Willem Grootjans et al. Nature Reviews Clinical Oncology
- Lymph Node Ratio May Predict the Benefit of Postoperative Radiotherapy in Non–Small-Cell Lung Cancer
- (2013) Damien Urban et al. Journal of Thoracic Oncology
- Modern post-operative radiotherapy for stage III non-small cell lung cancer may improve local control and survival: A meta-analysis
- (2013) Charlotte Billiet et al. RADIOTHERAPY AND ONCOLOGY
- Postoperative Radiotherapy for Patients With Completely Resected Pathologic N2 Non–Small-Cell Lung Cancer: A Retrospective Analysis
- (2012) Cristina Mantovani et al. Clinical Lung Cancer
- Role of Postoperative Radiotherapy in Resected Non-Small Cell Lung Cancer: A Reassessment Based on New Data
- (2011) C. Le Pechoux ONCOLOGIST
- Postoperative Radiotherapy for Resected Pathological Stage IIIA-N2 Non-Small Cell Lung Cancer: A Retrospective Study of 221 Cases from a Single Institution
- (2011) H. Dai et al. ONCOLOGIST
- Ratio of Metastatic Lymph Nodes to Total Number of Nodes Resected is Prognostic for Survival in Esophageal Carcinoma
- (2010) Clive J. Kelty et al. Journal of Thoracic Oncology
- The New Lung Cancer Staging System
- (2009) Frank C. Detterbeck et al. CHEST
- Lymph Node Ratio as an Alternative to pN Staging in Node-Positive Breast Cancer
- (2009) Vincent Vinh-Hung et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of Postoperative Radiation Therapy on Survival in Patients With Complete Resection and Stage I, II, or IIIA Non–Small-Cell Lung Cancer Treated With Adjuvant Chemotherapy: The Adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial
- (2008) Jean-Yves Douillard et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
- (2008) Jean-Pierre Pignon et al. JOURNAL OF CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started